With the increased availability of safe and effective treatments for patients with hepatitis C (HCV), Brian L. Pearlman, MD, FACP, FAASLD, AAHIVS, identified five HCV patient populations clinicians should understand how to treat.
Prateek Sharama, MD, provided a checklist for clinicians and organizations as endoscopic services resume post COVID-19 to ensure safe and efficient operation.
Kenneth Wang, MD, reviewed recent innovations in cryotherapy and tissue resection that are improving outcomes for patients with Barrett’s esophagus, especially those who have failed standard therapy.
Joseph C. Anderson, MD, FACG, MHCDS, provided a review of the best time to start and stop screening for colorectal cancer (CRC) to detect the cancer early and to prevent unnecessary screening.
Jacob E. Kurlander, MD, MS, of the Veterans Affairs (VA) Center for Clinical Management Research and Michigan Medicine shared data on the largest PPI deprescribing intervention in Veterans, showing that these programs help reduce PPI prescribing, without increasing adverse events.
Nancy Reau, MD, explored COVID-19-related liver disease in severe and long-term COVID-19 infections.
Nicholas J. Zyromski, MD, of Indiana University School of Medicine and Giovanni Marchegiani, MD, PhD, of Verona University Hospital in Italy debate whether post-pancreatectomy acute pancreatitis is a relevant clinical entity, and how to treat it.
Ji Young Bang, MD, provided insight into the gender-based inequities in the field of gastroenterology and gave suggestions for clinicians and institutions to prevent and overcome gender bias.
New data presented by Andy Tien, MD, MS, of Kaiser Permanente Medical Center in Los Angeles points to an increased risk of dying from COVID-19 in liver transplant patients.
ASGE President Klaus Mergener, MD, PhD, MBA, provided an overview of the top research from ASGE being presented at DDW 2021.
